Brooklyn ImmunoTherapeutics, Inc. announced on May 24, 2022, Heather Redman, Erich Mohr and Erin Enright delivered notices to the Board of their respective decisions not to stand for reelection at the Company's 2022 annual meeting of stockholders, currently scheduled for June 7, 2022. On May 26, 2022, Dennis Langer similarly delivered notice to the Board of his decision not to stand for reelection at the Annual Meeting. Ms. Redman, Ms. Enright, Dr. Mohr and Dr. Langer currently remain directors, and none of them has yet provided a specific date on which his or her Board service will cease, as the current Board actively interviews and seeks new candidates with appropriate qualifications to serve on the Board.

The decisions of the foregoing directors not to stand for reelection were not due to any disagreement with the Company on any matter relating to the Company's operations, policies or practices.